Skip to content
healthcare.dev

Cetirizine Hydrochloride

NDC 51655-801, Cetirizine Hydrochloride Tablets, tablet, film coated, from Northwind Health Company, LLC.

Product NDC
51655-801
Status
Listed
Labeler
Northwind Health Company, LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA078343
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51655-801 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
51655-801-525165508015230 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-801-52)
51655-801-6051655080160100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-801-60)
51655-801-845165508018414 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-801-84)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 51655-801 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51655-801 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51655-801. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.